Cranberry extract standardized for proanthocyanidins promotes the immune response of Caenorhabditis elegans to Vibrio cholerae through the p38 MAPK pathway and HSF-1

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Dinh, Jessica ^a   Angeloni, Joseph T ^a   Pederson, Daniel B ^a   Wang, Xiaoxia ^a   Cao, Min ^a   Dong, Yuqing ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRANBERRY EXTRACT; HEAT SHOCK TRANSCRIPTION FACTOR 1; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROANTHOCYANIDIN; SOMATOMEDIN C; CAENORHABDITIS ELEGANS PROTEIN; HEAT SHOCK FACTOR-1, C ELEGANS; PLANT EXTRACT; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; C23G10.1 GENE; CAENORHABDITIS ELEGANS; CHOLERA; CLEC 46 GENE; CLEC 71 GENE; CONTROLLED STUDY; CTXA GENE; DISEASE MODEL; FMO 2 GENE; GENE EXPRESSION; HAPR GENE; HLYA GENE; IMMUNOMODULATION; INNATE IMMUNITY; LUXO GENE; MOLECULAR MECHANICS; NONHUMAN; PQN 5 GENE; PRTV GENE; SIGNAL TRANSDUCTION; SUPPLEMENTATION; SURVIVAL TIME; TCPA GENE; TOXR GENE; TOXT GENE; UPREGULATION; YOUNG ADULT; AGING; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CRANBERRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; PATHOGENICITY; VIBRIO CHOLERAE;

AGING; ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INSULIN-LIKE GROWTH FACTOR I; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; PROANTHOCYANIDINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VACCINIUM MACROCARPON; VIBRIO CHOLERAE;

EID: 84904987406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103290     Document Type: Article

References (61)

1. Blumberg JB, Camesano TA, Cassidy A, Kris-Etherton P, Howell A, et al. (2013) Cranberries and Their Bioactive Constituents in Human Health. Adv Nutr 4: 618-632.
2. Neto CC (2011) Cranberries: ripe for more cancer research? J Sci Food Agric 91: 2303-2307.
3. Neto CC (2007) Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 51: 652-664.
4. Neto CC (2007) Cranberry and its phytochemicals: a review of in vitro anticancer studies. J Nutr 137: 186S-193S.
5. Wilson T, Porcari JP, Harbin D (1998) Cranberry extract inhibits low density lipoprotein oxidation. Life Sci 62: PL381-386.
6. Bradford PG (2013) Curcumin and obesity. Biofactors 39: 78-87.
7. Weisberg SP, Leibel R, Tortoriello DV (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149: 3549-3558. (Pubitemid 351919581)
8. Gonzalez-Vallinas M, Gonzalez-Castejon M, Rodriguez-Casado A, Ramirez de Molina A (2013) Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev 71: 585-599.
9. Meydani M, Hasan ST (2010) Dietary polyphenols and obesity. Nutrients 2: 737-751.
10. Scalbert A, Manach C, Morand C, Remesy C, Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45: 287-306. (Pubitemid 41657352)
11. Sacco SM, Horcajada MN, Offord E (2013) Phytonutrients for bone health during ageing. Br J Clin Pharmacol 75: 697-707.
12. Sies H (2010) Polyphenols and health: update and perspectives. Arch Biochem Biophys 501: 2-5.
13. Pappas E, Schaich KM (2009) Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr 49: 741-781.
14. Krueger CG, Reed JD, Feliciano RP, Howell AB (2013) Quantifying and characterizing proanthocyanidins in cranberries in relation to urinary tract health. Anal Bioanal Chem 405: 4385-4395.
15. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, et al. (2005) A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 66: 2281-2291. (Pubitemid 41254101)
16. Ferguson PJ, Kurowska EM, Freeman DJ, Chambers AF, Koropatnick J (2006) In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutr Cancer 56: 86-94. (Pubitemid 46173418)
17. Zou S, Carey JR, Liedo P, Ingram DK, Yu B (2012) Prolongevity effects of a botanical with oregano and cranberry extracts in Mexican fruit flies: examining interactions of diet restriction and age. Age (Dordr) 34: 269-279.
18. Guha S, Cao M, Kane RM, Savino AM, Zou S, et al. (2013) The longevity effect of cranberry extract in Caenorhabditis elegans is modulated by daf-16 and osr-1. Age (Dordr) 35: 1559-1574.
19. Sun Y, Yolitz J, Alberico T, Sun X, Zou S (2013) Lifespan extension by cranberry supplementation partially requires SOD2 and is life stage independent. Exp Gerontol 50C: 57-63.
20. Wang C, Yolitz J, Alberico T, Laslo M, Sun Y, et al. (2013) Cranberry Interacts With Dietary Macronutrients to Promote Healthy Aging in Drosophila. J Gerontol A Biol Sci Med Sci.
21. Guha S, Natarajan O, Murbach CG, Dinh J, Wilson EC, et al. (2014) Supplement Timing of Cranberry Extract Plays a Key Role in Promoting Caenorhabditis elegans Healthspan. Nutrients 6: 911-921.
22. Joshua GW, Karlyshev AV, Smith MP, Isherwood KE, Titball RW, et al. (2003) A Caenorhabditis elegans model of Yersinia infection: biofilm formation on a biotic surface. Microbiology 149: 3221-3229. (Pubitemid 37442005)
23. Labrousse A, Chauvet S, Couillault C, Kurz CL, Ewbank JJ (2000) Caenorhabditis elegans is a model host for Salmonella typhimurium. Curr Biol 10: 1543-1545. (Pubitemid 32003650)
24. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM (1999) Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96: 47-56. (Pubitemid 29044152)
25. Tan MW, Mahajan-Miklos S, Ausubel FM (1999) Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci U S A 96: 715-720. (Pubitemid 29061274)
26. Vaitkevicius K, Lindmark B, Ou G, Song T, Toma C, et al. (2006) A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci U S A 103: 9280-9285. (Pubitemid 43902569)
27. Marsh EK, May RC (2012) Caenorhabditis elegans, a model organism for investigating immunity. Appl Environ Microbiol 78: 2075-2081.
28. Kurz CL, Ewbank JJ (2003) Caenorhabditis elegans: an emerging genetic model for the study of innate immunity. Nat Rev Genet 4: 380-390.
29. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, et al. (2002) A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297: 623-626. (Pubitemid 34815350)
30. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, et al. (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424: 277-283.
31. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, et al. (2006) p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet 2: e183.
32. Zugasti O, Ewbank JJ (2009) Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat Immunol 10: 249-256.
33. Alm RA, Guerry P, Power ME, Lior H, Trust TJ (1991) Analysis of the role of flagella in the heat-labile Lior serotyping scheme of thermophilic Campylobacters by mutant allele exchange. J Clin Microbiol 29: 2438-2445.
34. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, et al. (2002) Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A 99: 3129-3134. (Pubitemid 34240597)
35. Cinar HN, Kothary M, Datta AR, Tall BD, Sprando R, et al. (2010) Vibrio cholerae hemolysin is required for lethality, developmental delay, and intestinal vacuolation in Caenorhabditis elegans. PLoS One 5: e11558.
36. Sahu SN, Lewis J, Patel I, Bozdag S, Lee JH, et al. (2012) Genomic analysis of immune response against Vibrio cholerae hemolysin in Caenorhabditis elegans. PLoS One 7: e38200.
37. Thelin KH, Taylor RK (1996) Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect Immun 64: 2853-2856.
38. Liu Z, Yang M, Peterfreund GL, Tsou AM, Selamoglu N, et al. (2011) Vibrio cholerae anaerobic induction of virulence gene expression is controlled by thiol-based switches of virulence regulator AphB. Proc Natl Acad Sci U S A 108: 810-815.
39. Gandhi S, Santelli J, Mitchell DH, Stiles JW, Sanadi DR (1980) A simple method for maintaining large, aging populations of Caenorhabditis elegans. Mech Ageing Dev 12: 137-150. (Pubitemid 10113067)
40. Hosono R (1978) Sterilization and growth inhibition of Caenorhabditis elegans by 5-fluorodeoxyuridine. Exp Gerontol 13: 369-374.
41. Hosono R, Mitsui Y, Sato Y, Aizawa S, Miwa J (1982) Life span of the wild and mutant nematode Caenorhabditis elegans. Effects of sex, sterilization, and temperature. Exp Gerontol 17: 163-172. (Pubitemid 12086314)
42. Mitchell DH, Stiles JW, Santelli J, Sanadi DR (1979) Synchronous growth and aging of Caenorhabditis elegans in the presence of fluorodeoxyuridine. J Gerontol 34: 28-36. (Pubitemid 9101693)
43. Ray S, Chatterjee E, Chatterjee A, Paul K, Chowdhury R (2011) A fadD mutant of Vibrio cholerae is impaired in the production of virulence factors and membrane localization of the virulence regulatory protein TcpP. Infect Immun 79: 258-266.
44. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. (Pubitemid 351818697)
45. Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, et al. (2006) Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A 103: 10414-10419. (Pubitemid 44051181)
46. Sifri CD, Begun J, Ausubel FM, Calderwood SB (2003) Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect Immun 71: 2208-2217. (Pubitemid 36368756)
47. Schulenburg H, Ewbank JJ (2004) Diversity and specificity in the interaction between Caenorhabditis elegans and the pathogen Serratia marcescens. BMC Evol Biol 4: 49.
48. Hsiao JY, Chen CY, Yang MJ, Ho HC (2013) Live and dead GFP-tagged bacteria showed indistinguishable fluorescence in Caenorhabditis elegans gut. J Microbiol 51: 367-372.
49. Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, et al. (2003) Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300: 1921. (Pubitemid 36734593)
50. Singh V, Aballay A (2006) Heat shock and genetic activation of HSF-1 enhance immunity to bacteria. Cell Cycle 5: 2443-2446. (Pubitemid 44785819)
51. Singh V, Aballay A (2006) Heat-shock transcription factor (HSF)-1 pathway required for Caenorhabditis elegans immunity. Proc Natl Acad Sci U S A 103: 13092-13097. (Pubitemid 44338921)
52. Chiang WC, Ching TT, Lee HC, Mousigian C, Hsu AL (2012) HSF-1 regulators DDL-1/2 link insulin-like signaling to heat-shock responses and modulation of longevity. Cell 148: 322-334.
53. Cohen E, Du D, Joyce D, Kapernick EA, Volovik Y, et al. (2010) Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection. Aging Cell 9: 126-134.
54. Volovik Y, Maman M, Dubnikov T, Bejerano-Sagie M, Joyce D, et al. (2012) Temporal requirements of heat shock factor-1 for longevity assurance. Aging Cell 11: 491-499.
55. Son MS, Megli CJ, Kovacikova G, Qadri F, Taylor RK (2011) Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes. J Clin Microbiol 49: 3739-3749.
56. Gardel CL, Mekalanos JJ (1996) Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. Infect Immun 64: 2246-2255. (Pubitemid 26165686)
57. Shmuely H, Ofek I, Weiss EI, Rones Z, Houri-Haddad Y (2012) Cranberry components for the therapy of infectious disease. Curr Opin Biotechnol 23: 148-152.
58. Shivers RP, Pagano DJ, Kooistra T, Richardson CE, Reddy KC, et al. (2010) Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 MAPK regulates innate immunity in Caenorhabditis elegans. PLoS Genet 6: e1000892.
59. Muralidharan S, Mandrekar P (2013) Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol 94: 1167-1184.
60. Liu Y, Chang A (2008) Heat shock response relieves ER stress. EMBO J 27: 1049-1059. (Pubitemid 351508152)
61. Engelmann I, Pujol N (2010) Innate immunity in C. elegans. Adv Exp Med Biol 708: 105-121.